SUCCESSFUL TREATMENT OF VENOOCCLUSIVE DISEASE OF THE LIVER WITH UROKINASE IN A PATIENT WITH NON-HODGKINS-LYMPHOMA

AJ FOGTELOO, WM SMID, T KOK, J VANDERMEER, GW VANIMHOFF, S DAENEN

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

    9 Citations (Scopus)

    Abstract

    A 38-year-old man with a non-Hodgkin's lymphoma of intermediate grade malignancy attained partial remission after three courses of CHOP (cyclophosphamide + hydroxydaunorubicin + vincristine + prednisolone). He was assigned to undergo autologous bone marrow transplantation (ABMT). The conditioning regimen consisted of cyclophosphamide and whole body irradiation. Two weeks later he developed veno-occlusive disease (VOD) of the liver. Doppler sonography confirmed the diagnosis showing a reversal of the blood flow in the portal vein. In addition a large thrombus was present in the interior caval vein. Protein C level was strongly reduced (28%). Because of clinical deterioration intravenous urokinase was started. The transaminases normalised rapidly and the patient showed a dramatic clinical improvement. There were no major bleeding complications. Repeat Doppler sonography showed a normal antegrade flow in the portal vein. This case suggests that a coagulopathy in the hepatic vascular bed might contribute to the development of VOD and that patients with VOD are st risk for other thrombotic complications. Furthermore it shows that urokinase with platelet support can be given safely and effectively to a patient with VOD and severe thrombocytopenia.

    Original languageEnglish
    Pages (from-to)760-763
    Number of pages4
    JournalLeukemia
    Volume7
    Issue number5
    Publication statusPublished - May-1993

    Keywords

    • BONE-MARROW TRANSPLANTATION
    • HEPATIC VENOOCCLUSIVE DISEASE
    • VENOCCLUSIVE DISEASE
    • CLINICAL COURSE
    • SOLID TUMORS
    • CHEMOTHERAPY

    Fingerprint

    Dive into the research topics of 'SUCCESSFUL TREATMENT OF VENOOCCLUSIVE DISEASE OF THE LIVER WITH UROKINASE IN A PATIENT WITH NON-HODGKINS-LYMPHOMA'. Together they form a unique fingerprint.

    Cite this